Search

[EN] The Baranyi-Roberts model describes the dynamics of the volumetric densities of two interacting cell populations. We randomize this model by considering that the initial conditions are random variables whose distributions are determined by using sample data and the principle of maximum entropy. Subsequenly, we obtain the Liouville-Gibbs partial differential equation for the probability density function of the two-dimensional solution stochastic process. Because the exact solution of this equation is unaffordable, we use a finite volume scheme to numerically approximate the aforementioned probability density function. From this key information, we design an optimization procedure in order to determine the best growth rates of the Baranyi-Roberts model, so that the expectation of the numerical solution is as close as possible to the sample data. The results evidence good fitting that allows for performing reliable predictions., This work has been supported by the Spanish Ministerio de Economia, Industria y Competitividad (MINECO), the Agencia Estatal de Investigacion (AEI) and Fondo Europeo de Desarrollo Regional (FEDER UE) grant MTM2017-89664-P.

Bladder cancer is one of the most common malignant diseases in the urinary system and a highly aggressive neoplasm. The prognosis is not favourable usually and its evolution for particular patients is very difficult to find out. In this paper we propose a dynamic mathematical model that describes the bladder tumor growth and the immune response evolution. This model is customized for a single patient, determining appropriate model parameter values via model calibration. Due to the uncertainty of the tumor evolution, using the calibrated model parameters, we predict the tumor size and the immune response evolution over the next few months assuming three different scenarios: favourable, neutral and unfavourable. In the former, the cancer disappears; in the second a 5mm tumor is expected around the middle of August 2018; in the worst scenario, a 5mm tumor is expected around the end of May 2018. The patient has been cited around June 15th, 2018, to check the tumor size, if it exists.